American Oriental Bioengineering Announces September Investor Conferences Participation

Thursday, September 17, 2009 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Sept. 8 American OrientalBioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceuticalcompany dedicated to improving health through the development, manufacture andcommercialization of a broad range of prescription and over the counter ("OTC")products, today announced the Company's participation in the followingconferences:

For further details, please contact your respective institutional salesrepresentative.

About American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc. is a pharmaceutical companydedicated to improving health through the development, manufacture andcommercialization of a broad range of prescription and over the counterproducts.-- Morgan Stanley Healthcare Corporate Day, to be held September 11, 2009 in Boston, MA. Management will meet with institutional investors throughout the day. -- Morgan Stanley Global Healthcare Unplugged Conference, to be held September 14-15, 2009 in New York City. Management will meet with institutional investors throughout both days. -- Merrill Lynch/Bank of America Global Drug, Biotech & Medical Devices Conference, to be held September 15-17, 2009 in London. Management will present at 1:45pm London Time on September 16, 2009 and meet with institutional investors throughout all three days. A live webcast of the presentation will be available via the Company's website at http://www.bioaobo.com/ . -- Susquehanna Financial Group Third Annual Beijing Management Summit, to be held September 16-17, 2009 in Beijing, China. Management will speak on a panel discussion entitled, "China Pharma/Biotech Panel Participants," scheduled from 1:05-2:10pm Beijing Time on September 16, 2009. In addition, management will also present at 9:45am Beijing Time on September 16, 2009 and meet with institutional investors throughout both days.

SOURCE American Oriental Bioengineering, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook